TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET
Company Participants
Alexandra Grossman - Associate Director with LifeSci Advisors, IR
Mary Szela - President and CEO
James Young - CFO
Richard Marshall - Medical Director
Conference Call Participants
Justin Walsh - JonesTrading
Ross Osborne - Cantor Fitzgerald
Frank Takkinen - Lake Street Capital Markets
Suraj Kalia - Oppenheimer
William Plovanic - Canaccord
Jason Witz - ROTH
Operator
Good morning and welcome to TriSalus Life Sciences First Quarter 2025 Earnings Conference Call. Currently, all participants are on a listen-only mode. We will be facilitating a question-and-answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Alex Grossman, Associate Director with LifeSci Advisors. Please go ahead.
Alexandra Grossman
Thank you, Operator, and thank you all for participating in today's call. Joining me today from TriSalus Life Sciences are Mary Szela, President and Chief Executive Officer, James Young, Chief Financial Officer, and Dr. Richard Marshall, Medical Director.
Ms. Szela will provide an overview of the company's first quarter results and strategy for the balance of the year, and then Jim will review the financial results for the quarter in detail. Dr. Marshall will join the call to help address questions from the covering analysts. Earlier this morning, TriSalus released its financial results for the quarter ended March 31, 2025. A copy of this press release is available on the TriSalus website.
Before we begin, I would like to remind you that management will make statements during this call that includes forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Any statements contained in
- Read more current TLSI analysis and news
- View all earnings call transcripts